Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Pediatric Plexiform Neurofibromas

Key points about plexiform neurofibroma:

  • Plexiform neurofibromas are a common complication of neurofibromatosis.
  • Diagnosed through physical examinations. However, the full extent of the lesion is best seen by MRI scans.
  • Approximately 75 percent of patients who undergo a complete removal of the tumor — without causing significant neurologic impairment or dysfunction — are cured.

Children's National Hospital is a member of the Department of Defense Neurofibromatosis Clinical Trials Consortium — of which Roger Packer, M.D. acts as group chair. Children's National completed a trial evaluating a new biologic agent, Pirfenidone, and is currently evaluating the efficacy of another biologic agent, Rapamycin, (through the Department of Defense Consortium), which is designed to inhibit the proliferation of plexiform neurofibromas.

  • What are plexiform neurofibromas?
  • What causes plexiform neurofibromas?
  • What are the risk factors of plexiform neurofibromas?
  • How are plexiform neurofibromas treated?
  • Can all plexiform neurofibromas be surgically removed?
  • How common are plexiform neurofibromas?
  • How are plexiform neurofibromas diagnosed?